[Form 4] Lite Strategy, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lite Strategy, Inc. (LITS)11/14/2025, he was granted options to purchase 55,000 shares of Lite Strategy common stock at an exercise price of $2.02 per share, expiring on 11/14/2035. These options are held as direct ownership.

The options vest over time as board compensation. 16.66666% of the grant vested on the grant date, with the remaining options vesting in equal monthly installments beginning 12/14/2025 and continuing on the first day of each month through 11/14/2026. The filing states the grant was received as compensation for service on the company’s Board of Directors.

11/19/2025 - 01:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glover Nicholas

(Last) (First) (Middle)

C/O LITE STRATEGY, INC

9920 PACIFIC HEIGHTS BLVD., SUITE 150

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lite Strategy, Inc. [ LITS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.02	11/14/2025		A		55,000		(1)	11/14/2035	Common Stock	55,000	(2)	55,000	D

Explanation of Responses:

1. Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026.

2. Received as compensation for service on the Board.

	/s/ Nicholas Glover	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lite Strategy (LITS) disclose in this Form 4 filing?

Lite Strategy (LITS) disclosed that director Nicholas Glover received a grant of 55,000 stock options as part of his compensation for serving on the company’s Board of Directors.

How many Lite Strategy (LITS) stock options were granted and at what price?

The filing reports a grant of 55,000 stock options with an exercise price of $2.02 per share, allowing the holder to buy Lite Strategy common stock at that price.

When do the newly granted Lite Strategy (LITS) options vest?

According to the disclosure, 16.66666% of the options vested on 11/14/2025, and the remaining options vest in equal monthly amounts starting on 12/14/2025 and continuing through 11/14/2026.

What is the expiration date of the Lite Strategy (LITS) director stock options?

The stock options granted to the director expire on 11/14/2035, giving a 10-year term from the grant date.

Is this Lite Strategy (LITS) Form 4 transaction a purchase or a compensation grant?

The filing states that the options were received as compensation for service on the Board and are described as a customary annual grant to non-employee directors.

How many derivative securities does the reporting person hold after this Lite Strategy (LITS) transaction?

After the reported transaction, the director beneficially owns 55,000 derivative securities (stock options) directly, as shown in the Form 4 table.